May 24th, 2012
A new immunotherapy for companion dogs with advanced-stage non-Hodgkin lymphoma (NHL) has been shown to improve survival while maintaining quality of life, according to a study published in the journal Scientific Reports. The study resulted from a collaboration between The University of Texas MD Anderson Childrenâs Cancer Hospital in Houston and Texas A&M University College of . . . â Read More: Canine Lymphoma
May 23rd, 2012
A team of researchers from the University of Pennsylvania School of Veterinary Medicine and Pennâs Perelman School of Medicine has the first evidence that an Epstein Barr-like virus can infect and may also be responsible for causing lymphomas in manâs best friend.
Dogs develop lymphomas that share some characteristics with the human equivalents. These conditions are relatively . . . â Read More: Epstein Barr type virus and Lymphoma in Dogs
March 24th, 2012
02.23.12
Texas A&M , UT MD Anderson Team Up to Treat Canine Lymphoma
HOUSTON â A new immunotherapy for companion dogs with advanced-stage non-Hodgkin lymphoma (NHL) has been shown to improve survival while maintaining quality of life, according to a study published in the journal Scientific Reports. The study resulted from a collaboration between The University of Texas MD Anderson Childrenâs Cancer Hospital in Houston and Texas A&M University College of Veterinary Medicine in College Station. Continue reading Canine Lymphoma treatment
October 29th, 2011
October 18, 2011
PHILADELPHIA â An experimental vaccine developed by researchers at the University of Pennsylvaniaâs schools of Medicine and Veterinary Medicine is the first veterinary cancer vaccine of its kind that shows an increase in survival time for dogs with spontaneous non-Hodgkinâs lymphoma. The work shows for the first time the feasibility and therapeutic efficacy of this alternative cell-based vaccine, which could be employed in the treatment of a number of different cancer types.
The research was conducted by Nicola Mason, assistant professor of medicine at Penn Vet; Robert H. Vonderheide, associate professor of hematology and oncology at the Perelman School of Medicine; and Karin U. Sorenmo, associate professor of oncology at Penn Vet. Erika Krick, Beth Overley and Thomas P. Gregor of Penn Vet and Christina M. Coughlin of the School of Medicine also contributed to the research.
July 22nd, 2011
Medical News Today Lymphoma Drug Shrinks Tumors In Dogs, Could Lead To Human Treatment
18 Jul 2011
There are many kinds of cancers of the immune system, but one, Activated B-Cell Diffuse Large B-Cell Lymphoma, or ABC-DLBCL, is particularly common and pernicious. Researchers at the University of Pennsylvaniaâs School of Veterinary Medicine have shown for the first time that dogs that develop this disease spontaneously share the same aberrant activation of a critical intracellular pathway with humans. They also found that a drug designed to disrupt this pathway helps to kill tumor cells in the dogsâ cancerous lymph nodes.
Continue reading Lymphoma Drug Shrinks Tumors In Dogs
May 19th, 2011
Veterinary Specialty Hospital Success With Its First Bone Marrow Transplant In Dog With Lymphoma
Veterinary Specialty Hospital of San Diego (VSH) has successfully performed a hematopoietic cell transplant (better known as bone marrow transplant) for a dog with lymphoma. Cody, an otherwise active and healthy 7-year old male Golden Retriever completed his treatment and is thriving with no complications 4 months after his discharge from the hospital. Continue reading Bone Marrow Transplant in Dog
没有评论:
发表评论